Enhanced antiviral benefit of combination therapy with anti-HBV and anti-PD1 gRNA/cas9 produces a synergistic antiviral effect in HBV infection
Shuai Zhen, Rong Qiang, Jiaojiao Lu, Xiaoqian Tuo, Xiling Yang, Xu Li
Topics & Concepts
CD80BiologyImmune systemCD86Hepatitis B virusGenetic enhancementHBsAgCancer researchInterferonImmunologyVirologyT cellVirusCytotoxic T cellIn vitroCD40GeneBiochemistryHepatitis B Virus StudiesImmunotherapy and Immune ResponsesViral Infections and Outbreaks Research